IL320448A - Methods of treating cancer with sotorasib - Google Patents
Methods of treating cancer with sotorasibInfo
- Publication number
- IL320448A IL320448A IL320448A IL32044825A IL320448A IL 320448 A IL320448 A IL 320448A IL 320448 A IL320448 A IL 320448A IL 32044825 A IL32044825 A IL 32044825A IL 320448 A IL320448 A IL 320448A
- Authority
- IL
- Israel
- Prior art keywords
- sotorasib
- methods
- treating cancer
- cancer
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263418695P | 2022-10-24 | 2022-10-24 | |
| PCT/US2023/035736 WO2024091463A1 (en) | 2022-10-24 | 2023-10-23 | Methods of treating cancer with sotorasib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL320448A true IL320448A (en) | 2025-06-01 |
Family
ID=88839813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL320448A IL320448A (en) | 2022-10-24 | 2023-10-23 | Methods of treating cancer with sotorasib |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4608406A1 (en) |
| JP (1) | JP2025535477A (en) |
| KR (1) | KR20250092216A (en) |
| CN (1) | CN120091823A (en) |
| AU (1) | AU2023366820A1 (en) |
| CL (1) | CL2025001198A1 (en) |
| IL (1) | IL320448A (en) |
| MX (1) | MX2025004716A (en) |
| TW (1) | TW202423431A (en) |
| WO (1) | WO2024091463A1 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112023018734A2 (en) * | 2021-03-17 | 2023-10-24 | Amgen Inc | SOTORASIB DOSING REGIMES |
-
2023
- 2023-10-23 WO PCT/US2023/035736 patent/WO2024091463A1/en not_active Ceased
- 2023-10-23 EP EP23808984.1A patent/EP4608406A1/en active Pending
- 2023-10-23 JP JP2025523543A patent/JP2025535477A/en active Pending
- 2023-10-23 AU AU2023366820A patent/AU2023366820A1/en active Pending
- 2023-10-23 KR KR1020257015863A patent/KR20250092216A/en active Pending
- 2023-10-23 CN CN202380074647.6A patent/CN120091823A/en active Pending
- 2023-10-23 IL IL320448A patent/IL320448A/en unknown
- 2023-10-23 TW TW112140397A patent/TW202423431A/en unknown
-
2025
- 2025-04-23 CL CL2025001198A patent/CL2025001198A1/en unknown
- 2025-04-23 MX MX2025004716A patent/MX2025004716A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2025001198A1 (en) | 2025-08-01 |
| JP2025535477A (en) | 2025-10-24 |
| AU2023366820A1 (en) | 2025-06-12 |
| WO2024091463A1 (en) | 2024-05-02 |
| KR20250092216A (en) | 2025-06-23 |
| TW202423431A (en) | 2024-06-16 |
| EP4608406A1 (en) | 2025-09-03 |
| MX2025004716A (en) | 2025-05-02 |
| CN120091823A (en) | 2025-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4111202A4 (en) | Methods of treating cancer | |
| IL284850A (en) | Methods of treating breast cancer with tucatinib | |
| CA3256390A1 (en) | Methods of treating cancer with an mtor inhibitor | |
| IL320332A (en) | Methods for treating cancer | |
| IL289811A (en) | Method of treating cancer | |
| SG11202107017TA (en) | Methods of treating cancer | |
| CA3253688A1 (en) | Methods of treating small cell lung cancer | |
| IL305780A (en) | Methods for the treatment of cancer | |
| GB202107994D0 (en) | Treatment of cancer | |
| IL320743A (en) | Method of treating prostate cancer | |
| IL307556A (en) | Methods of treating cancer with anti-tigit antibodies | |
| IL320448A (en) | Methods of treating cancer with sotorasib | |
| IL314687A (en) | Treatment of cancer | |
| IL315569A (en) | Methods of treating cancer | |
| IL312332A (en) | Methods of treating cancer | |
| IL290213A (en) | Methods of treating multifocal cancer | |
| IL272390A (en) | Methods of treating cancer | |
| EP4284820A4 (en) | Methods of treating cancer with poziotinib | |
| IL314798A (en) | Methods of treating prostate cancer | |
| HK40109326A (en) | Methods of treating cancer | |
| IL314034A (en) | Treatment of ovarian cancer with nirogacestat | |
| AU2024274880A1 (en) | Methods of treating cancer | |
| GB202311976D0 (en) | Treatment of cancer | |
| GB202218181D0 (en) | Treatment of cancer | |
| GB202201803D0 (en) | Treatment of Cancer |